Nepsone Ehf
Reykjavik, IS· latest recorded location
NEPSONE EHF is named on 4 US grants and 5 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 4
- Published applications
- 5
- Inventors
- 1
- Granted in 2026 so far
- 0
- Most recent grant
- 6 Dec 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 3 |
| 2021 | 0 | 0 |
| 2022 | 3 | 0 |
| 2023 | 0 | 1 |
By publication year.
Technology areas
Share of 9 documents
Recent patents
- Methods of treating inflammatory skin disorders6 Dec 2022US 11,517,612 B2
- Methods of treating inflammatory skin disorders6 Sep 2022US 11,433,119 B2
- Methods of treating inflammatory skin disorders8 Mar 2022US 11,266,718 B2
- Use of CGRP antagonist compounds for treatment of psoriasis2 Jun 2020US 10,668,132 B2
- Methods of treating inflammatory skin disorders15 Jun 2023US 2023/0181693 A1
- Methods of treating inflammatory skin disorders29 Oct 2020US 2020/0338168 A1
- Methods of treating inflammatory skin disorders29 Oct 2020US 2020/0338169 A1
- Methods of treating inflammatory skin disorders29 Oct 2020US 2020/0338170 A1
- Use of cgrp antagonist compounds for treatment of psoriasis9 Mar 2017US 2017/0065681 A1
Most cited
By later US patents